Baxter Update Regarding Intralipid

Baxter has provided this customer letter on current challenges regarding its third party manufacturer’s delivery of INTRALIPID (20% I.V. Fat Emulsion). The letter provides information about allocation of the product. Baxter’s Medical Affairs team is available for clinical support or questions to assist during this supply constraint. Contact Baxter Medical Affairs at [email protected] or by visiting https://Medinfo.baxter.com.